Review: Prostaglandins and cancer

Prostaglandines and Medicine

Volumn 5, Issue 1, 1980, Pages 11-28

  Karmali, Rashida A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16,16 DIMETHYLPROSTAGLANDIN E2 METHYL ESTER; 3 METHYLCHOLANTHRENE; ACETYLSALICYLIC ACID; AFLATOXIN B1; COLCHICINE; FLURBIPROFEN; INDOMETACIN; MELATONIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN; PROSTAGLANDIN A1; PROSTAGLANDIN A2; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

1,2,7,8 DIEPOXYOCTANE; CANCER; CARCINOGENESIS; CELL GROWTH; DRUG INTERACTION; DRUG SCREENING; DRUG SYNTHESIS; HUMAN CELL; HYPERCALCEMIA; METASTASIS; NONBIOLOGICAL MODEL; REVIEW; THEORETICAL STUDY;

ANIMAL; CELLS, CULTURED; CYCLIC AMP; CYCLOOXYGENASE INHIBITORS; HUMAN; HYPERCALCEMIA; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PROSTAGLANDINS; PROSTAGLANDINS E; PROSTAGLANDINS F; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0018823357     PISSN: 01614630     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-4630(80)90086-5     Document Type: Review

References (109)

1. 2, and prostacyclin
2. Synthesis and metabolism of prostaglandins, prostacyclin and thromboxanes: The arachidonic acid cascade
3. 2α and rates of cell proliferation
4. The effect of prostaglandin on tumor implantation
5. Prostaglandin E and F in endocrine diarrheagenic syndromes
6. 2 carcinoma: Effects of hydrocortisone and indomethacin
7. Prostaglandins and cancer
8. Enhancement of carcinogenesis by prostaglandins
9. Human breast tumor-induced osteolysis and prostaglandins
10. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer
11. Inhibition of tumor growth in vivo and in vitro by prostaglandin E
12. 2-dibutyryl adenosine 3′:5′-cyclic monophosphate
13. The relationship between concentrations of PGE and rates of cell replication
14. Toxicity of prostaglandins Al and A2 for cells in culture
15. 2
16. 2α on the growth of a hormone-dependent rat mammary tumor
17. Prostaglandin production by experimental tumors and effects of anti-inflammatory compounds
18. 1 and dibutyryl cyclic AMP in normal adrenal cells and adrenal tumor cells from humans
19. Cellular basis of prolactin action: involvement of cyclic nucleotides, polyamines, prostaglandins, steroids, thyroid hormones, Na/KATPases and calcium: Relevance to breast cancer and the menstrual cycle
20. Enhancement of carcinogenesis by prostaglandins
21. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
22. Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids
23. Estrogen-related increases in uterine guanosine 3′-5′cyclic monophosphate levels
24. 2 alpha
25. 2. A new model for the hyper calcemia of cancer
26. Prostaglandin production by mouse fibrosarcoma cells in culture: Inhibition by indomethacin and aspirin
27. Arachidonic acid metabolism by cells in culture: Analyses of culture fluids for cyclooxygenase products by radioimmunoassay before and after separation by high pressure liquid chromatography
28. Antiproliferative activity of anti-inflammatory drugs in two mammalian cell culture lines
29. 1 stimulated cyclic AMP accumulation in human synoriocytes
30. Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase
31. A novel effect of indomethacin on prostaglandin F2 alpha synthesis and metabolism by the human prostate
32. Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin producing fibrosarcoma
33. Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells
34. Effects of indomethacin on Moloney sarcoma virus-induced tumors
35. Prostaglandin and cancer
36. Studies of prostaglandins in rat mammary tumors induced by 7,12-dimethyl benzanthracene
37. The influence of diazepam administration in rats bearing the R3230AC mammary carcinoma
38. Macrophages and the tumor bearing host
39. Content and distribution of macrophages and lymphocytes in solid malignant human tumors
40. Macrophages synthesize and release prostaglandins in response to inflammatory stimuli
41. Pharmacological control of prostaglandin and thromboxane release from macrophages
42. Suppression of human Tcell mitogenesis by prostaglandins
43. A possible role of prostaglandins in the inhibition of natural and antibody-dependent cell-mediated cytotoxicity against tumor cells
44. Prostaglandin-producing suppressor cells in Hodgkin's disease
45. Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice
46. Mechanism of inhibition of tumor growth by aspirin and indomethacin
47. Cancer growth, response to treatment and survival time in mice: beneficial effect of prostaglandin synthesis inhibitor flurbiprofen
48. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice
49. Elevated prostaglandin synthetase activity in methylcholanthrene-transformed mouse BALB/3T3
50. Stimulation of prostaglandin biosynthesis by vasoactive substances in meth ylcholanthrenetransformed mouse BALB/3T3
51. Enhancement of carcinogenesis by prostaglandins in male albino swiss mice
52. Hemoglobin synthesis in murine virus induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulphoxide
53. Anomalous responses of tumor vasculature to norepinephrine and prostaglandin E2 in the rabbit
54. Hyperplastic liver nodules
55. Chemical carcinogenesis
56. Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential Address
57. Established principles and unresolved problems in carcinogenesis
58. Isolation and characterization of the cocarcinogenic principles from croton oil
59. Some biological aspects of skin carcinogenesis
60. Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture
61. Inhibition of adipose conversion of 3T3 fibroblasts by tumor promoters
62. Tumor promoters inhibit morphological differentiation in cultured mouse neuroblastoma cells
63. Stimulation of prostaglandin synthesis by tumor-promoting phorbol-12,13-diesters in canine kidney (MDCK) cells. Cycloheximide inhibits the stimulated prosta glandin synthesis, deacylation of lipids, and morphological changes
64. Interactions between adenovirus, a tumor promoter and chemical carcinogen in transformation of rat embryo cell cultures
65. Phorbol ester induced prostaglandin synthesis and [3H]-TPA metabolism by TPA.sensitive and TPA-resistant Friend erythroleukemia cells
66. Retinoids as well as tumor promoters enhance deacylation of cellular lipids and prostaglandin production in MDCK cells
67. 1,4-Diaminobutane (putresine), spermidine, and spermine
68. Vitamin A acid (retinaic acid), a potent inhibitor of 12-0-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis
69. On the molecular structure of receptors for carcinogens and same anticancer drugs
70. Influence of agents which modulate thromboxane A2 synthesis or action on R3230AC mam mary carcinoma
71. Does ultraviolet-evoked prostaglandin formation protect skin from actinic cancer
72. Chemical carcinogens stimulate canine kidney (MDCK) cells to produce prostaglandins
73. Elevated prostaglandins synthetase activity in methylcholanthrene-transformed mouse BALE/ 3T3
74. Prostaglandin secretion by medullary carcinoma of the thyroid
75. Breast cancer, prostaglandins and bone metastases
76. Bone destruction by breast tumors
77. Breast cancer, osteolysis, bone metastases and anti-osteolysic effect of aspirin
78. 2 levels in human breast carcinoma
79. Prostaglandin E and hypercalcemia in breast carcinoma: only a tumor marker
80. Prostaglandins, calcium metabolism and cancer
81. 2 carcinoma model in the rabbit
82. Effect of prostaglandin endoperoxides and metabolites on bone resorption in vitro
83. Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma
84. Plasma prostaglandin E in patients with cancer with or without hypercalcemia
85. Prostaglandin E in cancer patients
86. Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture
87. Characterization of the group of patients with the hypercalcemia of cancer who respond to treatment with prostaglandin synthesis inhibitors
88. Enhancement of anti-cancer activity of cytotoxic chemotherapy with protection of normal tissues by inhibition of PG synthesis
89. 2 in mice bearing the HSDMl fibrosarcoma
90. Prostaglandins, hypercalcemia and cancer
91. Calcium metabolism in breast cancer
92. Prostaglandins and metastasis
93. Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastasic potential
94. Survival time after surgery is inversely related to the amounts of prostaglandins extracted from human breast cancers
95. Breast cancer and prostaglandins: a new approach to treatment
96. Humoral similarities of carcinoid tumors and medullary carcinomas of the thyroid
97. Prostaglandins in aminepeptide secreting tumors
98. Prostaglandins in neural-crest tumors
99. Vasoactive substances in Kaposi's sarcoma
100. Prostaglandins extracted from tumors of human large bowel
101. Antihypertensive function of a renal-cell carcinoma